Newsletter signup
A Cancer Study’s Secret Funder
A clinical trial of Chugai Pharmaceutical’s cancer drug Xeloda had incredible results, but they failed to mention Chugai’s financial support. Internal documents obtained by Tansa told a different story.
-
Chugai Pharmaceutical’s “off-label use” request to the Japanese Breast Cancer Society
2020.12.01 18:06 Makoto Watanabe
-
Japanese Association of Medical Sciences took action
2020.09.11 19:22 Makoto Watanabe
-
Kyoto University Hospital threatens to call the police
2020.08.11 18:05 Makoto Watanabe
-
Doctor in charge avoids questions
2020.06.09 21:34 Makoto Watanabe
-
“Refer your inquiries to Dr. Toi”
2020.06.04 18:37 Makoto Watanabe
-
“No donation comes without strings attached”
2020.06.02 18:56 Makoto Watanabe
-
520-million-yen embezzlement not reported to police
2020.05.18 18:48 Makoto Watanabe
-
The phantom NPO
2020.05.11 18:38 Makoto Watanabe
-
“Chugai Pharmaceutical” written in the passbook
2020.05.07 18:42 Makoto Watanabe
-
Irrefutable proof
2020.04.28 18:52 Makoto Watanabe
-
The whistleblower
2020.04.27 18:13 Makoto Watanabe
-
“Nothing more than defamation”
2020.04.22 18:00 Makoto Watanabe